EE04176B1 - Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks - Google Patents

Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Info

Publication number
EE04176B1
EE04176B1 EE9700068A EE9700068A EE04176B1 EE 04176 B1 EE04176 B1 EE 04176B1 EE 9700068 A EE9700068 A EE 9700068A EE 9700068 A EE9700068 A EE 9700068A EE 04176 B1 EE04176 B1 EE 04176B1
Authority
EE
Estonia
Prior art keywords
selegiline
pct
medicament
manufacture
treatment
Prior art date
Application number
EE9700068A
Other languages
English (en)
Other versions
EE9700068A (et
Inventor
L�scher Wolfgang
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of EE9700068A publication Critical patent/EE9700068A/et
Publication of EE04176B1 publication Critical patent/EE04176B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EE9700068A 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks EE04176B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428444A DE4428444A1 (de) 1994-08-11 1994-08-11 Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
PCT/DE1995/000981 WO1996004897A1 (de) 1994-08-11 1995-07-27 Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Publications (2)

Publication Number Publication Date
EE9700068A EE9700068A (et) 1997-10-15
EE04176B1 true EE04176B1 (et) 2003-12-15

Family

ID=6525440

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700068A EE04176B1 (et) 1994-08-11 1995-07-27 Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks

Country Status (23)

Country Link
US (1) US5952388A (et)
EP (1) EP0774961B1 (et)
JP (1) JP3922307B2 (et)
CN (1) CN1081918C (et)
AT (1) ATE239458T1 (et)
AU (1) AU691316B2 (et)
BR (1) BR9508531A (et)
CA (1) CA2197176C (et)
CZ (1) CZ285681B6 (et)
DE (2) DE4428444A1 (et)
DK (1) DK0774961T3 (et)
EE (1) EE04176B1 (et)
ES (1) ES2199252T3 (et)
HU (1) HU223529B1 (et)
MY (1) MY116362A (et)
NO (1) NO314684B1 (et)
PL (1) PL188040B1 (et)
PT (1) PT774961E (et)
RU (1) RU2155584C2 (et)
SK (1) SK283205B6 (et)
TR (1) TR199500984A2 (et)
TW (1) TW448044B (et)
WO (1) WO1996004897A1 (et)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630035A1 (de) * 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
DK1441708T3 (da) 2001-11-05 2009-07-06 Krele Pharmaceuticals Llc Sammensætninger og fremgangsmåder til forögelse af föjelighed med terapier ved anvendelse af aldehyddehydrogenase-inhibitorer og behandling af alkoholisme
GB201715919D0 (en) * 2017-09-29 2017-11-15 Gw Res Ltd use of cannabinoids in the treatment of epilepsy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868218A (en) * 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
WO1992017169A1 (en) * 1991-04-04 1992-10-15 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
WO1992021333A2 (en) * 1991-05-24 1992-12-10 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5648087A (en) * 1993-03-09 1997-07-15 Sanofi Sante Nutrition Animale Anaesthetic pharmaceutical composition comprising a general anaesthetic and selegiline
US5462740A (en) * 1993-09-17 1995-10-31 Athena Neurosciences, Inc. Rectally-administered, epileptic-seizure-inhibiting composition

Also Published As

Publication number Publication date
SK283205B6 (sk) 2003-03-04
CN1155241A (zh) 1997-07-23
NO970607D0 (no) 1997-02-10
JPH10504029A (ja) 1998-04-14
MX9701031A (es) 1998-05-31
TR199500984A2 (tr) 1996-06-21
ES2199252T3 (es) 2004-02-16
AU2976095A (en) 1996-03-07
WO1996004897A1 (de) 1996-02-22
AU691316B2 (en) 1998-05-14
BR9508531A (pt) 1998-12-01
HUT77175A (hu) 1998-03-02
PL188040B1 (pl) 2004-11-30
RU2155584C2 (ru) 2000-09-10
DK0774961T3 (da) 2003-09-01
CZ40797A3 (en) 1997-07-16
TW448044B (en) 2001-08-01
NO314684B1 (no) 2003-05-05
CA2197176A1 (en) 1996-02-22
MY116362A (en) 2004-01-31
ATE239458T1 (de) 2003-05-15
EE9700068A (et) 1997-10-15
HU223529B1 (hu) 2004-08-30
PL318292A1 (en) 1997-06-09
JP3922307B2 (ja) 2007-05-30
DE4428444A1 (de) 1996-02-15
US5952388A (en) 1999-09-14
EP0774961A1 (de) 1997-05-28
EP0774961B1 (de) 2003-05-07
PT774961E (pt) 2003-09-30
CA2197176C (en) 2007-06-26
NO970607L (no) 1997-02-10
CZ285681B6 (cs) 1999-10-13
CN1081918C (zh) 2002-04-03
SK19997A3 (en) 1997-08-06
DE59510674D1 (de) 2003-06-12

Similar Documents

Publication Publication Date Title
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
PT777483E (pt) Metodos e meio para administrar farmacos
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
FI963070A0 (fi) Klooripyrimidiinivälituotteita
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE279919T1 (de) Agmatin für die behandlung neuropathischer schmerzen
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
EE9700068A (et) Selegiliini kasutamine epileptiliste haiguste raviks
BR0108261A (pt) Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
PT983300E (pt) Sais peptidicos de bpc com actividade organo-protectora, processo para a sua preparacao e sua utilizacao em terapia
ES2173977T3 (es) Uso de r-(z)-alfa-(metoxiimino)-alfa-(1-azabiciclo(2.2.2)oct-3-il)acetonitrilo para reducir la formacion de la proteina amilacea beta a4 en la enfermedad de alzheimer.
DK0863752T3 (da) Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.
UY26990A1 (es) Nuevas composiciones de medicamentos
ATE236630T1 (de) Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
BR0315917A (pt) Utilização do sal distrÈnico do ácido 2-[n,n-di(carboximetil)amino]-3-ciano-4-carboximetil-ti ofeno-5-carboxìlico para a obtenção de medicamentos destinados ao tratamento das dores gastroduodenais
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

HE1A Change of address
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080727